Ginkgolic acid C17:1
Ginkgolic acid C17:1 is a fatty acid synthase (FAS) inhibitor with an IC50 of 10.5 µM. Ginkgolic acid C17:1 shows anti-tumor activity by inhibiting the phosphorylation of STAT3 and inducing apoptosis. Ginkgolic acid C17:1 can block the interaction between S-RBD and ACE2, and has anti-SARS-CoV-2-S pseudovirus activity. Ginkgolic acid C17:1 inhibits the biofilm formation of enterohemorrhagic Escherichia coli and Staphylococcus aureus[1][2][3][4][5].
Product Specifications
CAS Number
[111047-30-4]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Apoptosis; Fatty Acid Synthase (FASN) ; PTEN; SARS-CoV; STAT
Type
Natural Products
Related Pathways
Anti-infection; Apoptosis; JAK/STAT Signaling; Metabolic Enzyme/Protease; PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/ginkgolic-acid-c17-1.html
Purity
99.80
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)C1=C(O)C=CC=C1CCCCCCCCC/C=C\CCCCCC
Molecular Formula
C24H38O3
Molecular Weight
374.56
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
STAT3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items